Targeting Medium-Chain Acyl-CoA Dehydrogenase for Glioblastoma

Authors

Fei Yu, The University of Texas MD Anderson Cancer Center
Paul Leonard, The University of Texas MD Anderson Cancer Center
Matthew Hamilton, The University of Texas MD Anderson Cancer Center
Francesca Puca, The University of Texas MD Anderson Cancer Center
Nhung Pham, The University of Texas MD Anderson Cancer Center
Norma Rogers, The University of Texas MD Anderson Cancer Center
Fernando Alvarez, The University of Texas MD Anderson Cancer Center
C Rodriguez, The University of Texas MD Anderson Cancer Center
Vinay Nair, The University of Texas MD Anderson Cancer Center
Narahari Akkaladevi, The University of Texas MD Anderson Cancer Center
Roopa Thapar, The University of Texas MD Anderson Cancer Center
Scott Vaccaro, The University of Texas MD Anderson Cancer Center
Andrea Mendiola, The University of Texas MD Anderson Cancer Center
Quanyun Xu, The University of Texas MD Anderson Cancer Center
Mary Geck Do, The University of Texas MD Anderson Cancer Center
Jason Cross, The University of Texas MD Anderson Cancer Center
Mick Soth, The University of Texas MD Anderson Cancer Center
Yongying Jiang, The University of Texas MD Anderson Cancer Center
Giulio Draetta, The University of Texas MD Anderson Cancer Center
Philip Jones, The University of Texas MD Anderson Cancer Center

Files

Abstract

View full abstract

DOI

https://doi.org/10.52519/00098

Publication Date

2022

Department

Institute for Applied Cancer Science

Research Category

Other

Recommended Citation

Yu, Fei; Leonard, Paul; Hamilton, Matthew; Puca, Francesca; Pham, Nhung; Rogers, Norma; Alvarez, Fernando; Rodriguez, C; Nair, Vinay; Akkaladevi, Narahari; Thapar, Roopa; Vaccaro, Scott; Mendiola, Andrea; Xu, Quanyun; Geck Do, Mary; Cross, Jason; Soth, Mick; Jiang, Yongying; Draetta, Giulio; and Jones, Philip, "Targeting Medium-Chain Acyl-CoA Dehydrogenase for Glioblastoma" (2022). Leading Edge of Cancer Research Symposium. 42.
doi:https://doi.org/10.52519/00098